The industry already has paid the Internal Revenue Service about $388 million since the 2.3% medical device tax went into effect in January, shifting funds that could be used to create jobs and advance research and development, writes Siemens Healthcare CEO Dr. Greg Sorensen. The passage of the Senate budget amendment to repeal the tax is a key step toward reversing its adverse effects and preserving U.S. leadership in the global medtech industry, he writes.
Device-tax repeal will keep U.S. edge in global medtech, exec says
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore